Annual report
4538.TEDINET S100OL98
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥49.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥49.3bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥46.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥45.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥2.4bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.2bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥832m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.9bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥707m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥894m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥970m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥69.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥69.9bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥69.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.7bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥70.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.8bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥36.2bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥34.5bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥33.7bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥32.3bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥32.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥32.6bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.1bn | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥7.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.1bn | at 2021-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2020-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.8bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.5bn | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥978m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥984m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.4bn | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥313m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥69m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥169.09 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.18 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.59 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.96 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.61 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,936.7 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,839.54 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,681.46 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,742.48 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,711.54 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.2% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.4% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.2% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,451,169 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,344 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 1,356 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 1,352 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 1,347 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 1,366 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2022-03-31 | 1288 pure |
| Real Estate Businessreportable segment | employees | at 2022-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,093
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes significant accounting policies financial statements (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes additional information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding allowances directly deducted from balances of assets (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding revaluation of land for business (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant_NonConsolidatedMember | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes leases financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYearDuration_NonConsolidatedMember | Original text (Japanese)当社は、医薬品事業の他に不動産の賃貸を営んでおりますが、重要性が乏しいことからセグメント情報の記載を省略しております。 | |
| Notes per share information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of corporate bonds financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of borrowings financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |